BioSpace News Archive

Acerus Pharmaceuticals Corporation announced the acceptance of a scientific abstract reporting the results of the NATESTO® Spermatogenesis Study by the Endocrine Society for presentation at their Annual Meeting.

Surmodics, Inc. announced that it will host a live webcast of its first quarter fiscal 2020 conference call on Wednesday, February 5, at 4 p.m. CT.

Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, today announced it has been accepted to Microsoft’s One Commercial Partner (OCP) program.

ClinOne is proud to announce our new Coordinator of the Month program to honor and highlight outstanding performance by clinical trial site coordinators using the ClinOne platform.

Fractyl Laboratories Inc. (Fractyl) today announced its first commercial partnership with HCA Healthcare UK (United Kingdom), making its Revita® treatment commercially available for the first time for patients with type 2 diabetes

Oncology Pharma, Inc. (OTCPK: ONPH) would like to inform investors that it has completed its relationship with Tulynode Biosciences, Inc., and will be focusing on anti-cancer drugs instead of medical devices.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 3,448,278 shares of common stock for a purchase price of $1.45 per share, for gross proceeds of approximately $5.0 million.

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide a current January 2020 update on several important corporate activities and achievements since the last update in October 2019.

Arrevus today announced the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation for ARV-1801 (sodium fusidate tablet) for the treatment of Cystic Fibrosis Pulmonary Exacerbations.

CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announces the first minimally invasive robotic implant of Cor® PATCH by Dr. Husam H. Balkhy, Professor of Surgery, and Director of Robotic and Minimally Invasive Cardiac Surgery at the University of Chicago Medicine.